April 26, 2024

Death by Illumination

Blue light absorption by pathogenic bacteria can lead to their death.The language of light has many dialects. They found that P. aeruginosa reacted in a different way depending on the intensity and length of exposure to blue light in the 450-460 nm range. While a two-hour light treatment session is an unwise addition to existing clinical wound care workflows, integrating blue light treatment with other drugs may minimize the time needed to achieve similar anti-bacterial results in the future. I. Plattfaut et al., “Characterization of blue light treatment for contaminated injuries: anti-bacterial effectiveness of 420, 455, and 480 nm light-emitting diode ranges versus common skin pathogens versus blue light-induced skin cell toxicity, Photobiomodul Photomed Laser Surg, 39( 5 ):339 -48, 2021.

Blue light absorption by pathogenic bacteria can lead to their death.The language of light has many dialects. Germs– the worlds oldest organisms– produce, sense, and react to light in various methods that direct their presence. They transform information encoded by different light wavelengths into biochemical small talk that drives their physiology, including recreation, development, and metabolism. In many cases, particular wavelengths of light delivered in just the best way act as a death sentence– a function that makes bacterial death by lighting a promising technique to dealing with infections.Burn injuries are particularly prone to infection. The standard of look after infected injuries involves antimicrobial treatment and debridement– the removal of infected and dead tissue. Sometimes, extensive surgical debridement is required. As bacteria develop more resistance to antimicrobial drugs, these techniques are becoming less reliable. Researchers search for innovative techniques to deal with contaminated burns, including exposing wounds to blue light within the 400-470 nm wavelength variety, which has actually understood antimicrobial properties.1-5 Bacteria for which blue light is deadly have photoreceptors that pick up the light and trigger harmful reactive oxygen types production and the destabilization of numerous cellular systems.2,6 In a current study released in Photobiomodulation, Photomedicine, and Laser Surgery, scientists examined the anti-bacterial impact of blue light phototherapy versus Pseudomonas aeruginosa– a typical burn injury pathogen.7 They used in vitro assays and a human wound skin design to examine whether blue light treatment lowers the P. aeruginosa concern and determined the particular strengths and treatment times needed to optimize anti-bacterial effects. Researchers explore phototherapy for antimicrobial resistant infections.The researchers utilized colony-forming unit assays to track the variety of bacteria growing in suspension in vitro after blue light treatment. They found that P. aeruginosa responded in a different way depending on the strength and length of exposure to blue light in the 450-460 nm range. Providing a higher intensity of blue light over the course of an hour was more reliable than a lower intensity delivered for two hours. Doubling the intensity of light delivered over two hours was the most effective at lowering bacterial number with time. For the contaminated in vitro skin injuries– donor skin biopsies seeded with P. aeruginosa– the latter was the only method that showed a significant anti-bacterial effect.Working out the nuances of a treatment regimen in vitro is an important primary step towards future scientific translation. While a two-hour light treatment session is an impractical addition to existing medical injury care workflows, combining blue light treatment with other drugs may minimize the time required to attain comparable antibacterial impacts in the future. As this and similar treatments advance to medical trials, scientists will continue to use the bacterial language of light in their quest to incorporate phototherapy into existing burn injury care protocols.References: P.J. Gwynne, M.P. Gallagher, “Light as a broad-spectrum antimicrobial,” Front Microbiol, 9:119, 10.3389/ fmicb.2018.00119, 2018. A.J. De Lucca et al., “Blue light (470 nm) efficiently inhibits bacterial and fungal growth,” Lett Appl Microbiol, 55( 6 ):460 -6, 2012. S.W. Josewin et al., “Inactivation of Listeria monocytogenes and Salmonella spp. on cantaloupe skins by blue light giving off diodes (LEDs),” Food Microbiol, 76:219 -25, 2018. V.V. Bumah et al., “The bactericidal impact of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus ( MRSA),” Lasers Med Sci, 30( 3 ):1153 -59, 2015. I. Plattfaut et al., “Characterization of blue light treatment for infected injuries: antibacterial efficacy of 420, 455, and 480 nm light-emitting diode arrays versus common skin pathogens versus blue light-induced skin cell toxicity, Photobiomodul Photomed Laser Surg, 39( 5 ):339 -48, 2021. J. Hadi et al., “Antimicrobial blue light versus pathogenic bacteria: mechanism, application in the food industry, obstacle innovations and potential resistance,” Foods, 9( 12 ):1895, 2020. M.D. Leder et al., “Phototherapy of Pseudomonas aeruginosa-infected wounds: preclinical assessment of antimicrobial blue light (450– 460 nm) using in vitro assays and a human injury skin design,” Photobiomod Photomed Laser Surg, 40( 12 ):800 -09, 2022..